共 50 条
- [21] The Clinical Outcomes and Toxicities of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaFRONTIERS IN ONCOLOGY, 2021, 10Zou, RuiYuan, Jing-JingLi, QiangDing, Jian-WuLiao, BingTu, Zi-WeiHu, Rong-HuanGong, DanHu, Jia-LiZeng, Lei
- [22] Phase II trial of neoadjuvant docetaxel and cisplatin followed by intensity-modulated radiotherapy with concurrent cisplatin in locally advanced nasopharyngeal carcinomaCancer Chemotherapy and Pharmacology, 2013, 71 : 1577 - 1583Ya Hua ZhongJing DaiXiao Yong WangCong Hua XieGang ChenLei ZengYun Feng Zhou
- [23] Phase II Trial of Docetaxel and Cisplatin Neoadjuvant Chemotherapy Followed by Intensity Modulated Radiation Therapy With Concurrent Cisplatin in Advanced Nasopharyngeal CarcinomaINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S207 - S207Zhong, Y.Zhou, Y.Xie, C.Wang, X.Zhou, F.Chen, G.
- [24] Phase II trial of neoadjuvant docetaxel and cisplatin followed by intensity-modulated radiotherapy with concurrent cisplatin in locally advanced nasopharyngeal carcinomaCANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (06) : 1577 - 1583Zhong, Ya HuaDai, JingWang, Xiao YongXie, Cong HuaChen, GangZeng, LeiZhou, Yun Feng
- [25] A phase II trial of induction NAB-paclitaxel and cisplatin followed by concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinomaORAL ONCOLOGY, 2017, 70 : 7 - 13Ke, Liang-RuXia, Wei-XiongQiu, Wen-ZeHuang, Xin-JunYu, Ya-HuiLiang, HuLiu, Guo-YingXiang, Yan-QunGuo, XiangLv, Xing
- [26] Gemcitabine and cisplatin versus docetaxel and cisplatin as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma from non-endemic area of ChinaJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (09) : 2369 - 2378Zang, JianXu, ManLi, ChenZhao, LinaLuo, ShanuanWang, JianhuaShi, Mei
- [27] Gemcitabine and cisplatin versus docetaxel and cisplatin as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma from non-endemic area of ChinaJournal of Cancer Research and Clinical Oncology, 2020, 146 : 2369 - 2378Jian ZangMan XuChen LiLina ZhaoShanuan LuoJianhua WangMei Shi
- [28] Induction chemotherapy regimen of docetaxel plus cisplatin vs docetaxel, cisplatin plus fluorouracil followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Preliminary results of a phase III multicenter randomized controlled trialANNALS OF ONCOLOGY, 2022, 33 : S1521 - S1521He, S.Wang, Y.Wang, C.Peng, Z.Chen, Y.
- [29] Efficacy of neoadjuvant docetaxel and cisplatin followed by concurrent cisplatin-radiotherapy in locally advanced nasopharyngeal carcinoma (NPC): A randomized phase II studyJOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)Hui, E. P.Ma, B. B.Leung, S. F.King, A.Mo, F.Kam, M. K.Yu, K. H.Kwan, W. H.Zee, B. C.Chan, A. T.
- [30] Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trialLANCET ONCOLOGY, 2016, 17 (11): : 1509 - 1520Sun, YingLi, Wen-FeiChen, Nian-YongZhang, NingHu, Guo-QingXie, Fang-YunSun, YanChen, Xiao-ZhongLi, Jin-GaoZhu, Xiao-DongHu, Chao-SuXu, Xiang-YingChen, Yuan-YuanHu, Wei-HanGuo, LingMo, Hao-YuanChen, LeiMao, Yan-PingSun, RuiAi, PingLiang, Shao-BoLong, Guo-XianZheng, Bao-MinFeng, Xing-LaiGong, Xiao-ChangLi, LingShen, Chun-YingXu, Jian-YuGuo, YingChen, Yu-MingZhang, FanLin, LiTang, Ling-LongLiu, Meng-ZhongMa, Jun